Clinical Trial

Maternal Grandmothers in the Born in Guangzhou Cohort Study

Study acronym: MGBIG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The MGBIG is a study exploring cross-generational effects in 5000 women and their children and grandchildren located in Guangzhou, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology and on explaining the cause of the disease from the perspective of "grandmother-mother-child" heredity. Data are collected regarding environmental exposures, lifestyle, and social support on grandmother from birth to old age. Biological samples including blood and tissue samples are collected.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-08-13; most recent amendment 2024-09-27.
Trial Details
NCT Number NCT03633162
Lead Sponsor Guangzhou Women and Children's Medical Center
Collaborators: Children's Hospital Medical Center, Cincinnati, University of Birmingham
Conditions Hereditary Transmission, Immune Development, Childhood Obesity, Host and Microbiome, Neurodevelopment
Enrollment 5,000 participants
Start Date 2018-05-21
Primary Completion 2025-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-01